Potential Mechanism of Jiaotaiwan for Diabetes Based on Integrative Pharmacology Method

Can-can DUAN; Xian WU; Wen-bi MU; Sha YANG; Qi-hong CHEN; Kuan CHEN; Jian-yong ZHANG

doi:10.13422/j.cnki.syfjx.20190807

您当前的位置：

首页 >

文章列表页 >

Potential Mechanism of Jiaotaiwan for Diabetes Based on Integrative Pharmacology Method

Data Mining | 更新时间：2021-02-09

- Potential Mechanism of Jiaotaiwan for Diabetes Based on Integrative Pharmacology Method
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 8, Pages: 133-140(2019)
- 作者机构：
  
  1.遵义医科大学　基础药理教育部重点实验室暨特色民族药教育部国际合作联合实验室，贵州　遵义　 563003；
  2.遵义医科大学　药学院，贵州　遵义　 563009
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20190807
  CLC： R2-0;R22;R285.5;R289
- Received：19 September 2018，
  
  Published Online：04 January 2019，
  
  Published：20 April 2019
- 稿件说明：
移动端阅览
Can-can DUAN, Xian WU, Wen-bi MU, et al. Potential Mechanism of Jiaotaiwan for Diabetes Based on Integrative Pharmacology Method[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(8): 133-140.
DOI：

Can-can DUAN, Xian WU, Wen-bi MU, et al. Potential Mechanism of Jiaotaiwan for Diabetes Based on Integrative Pharmacology Method[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(8): 133-140. DOI： 10.13422/j.cnki.syfjx.20190807.

摘要

目的：

交泰丸为中医治疗失眠的经典方剂，目前临床采用异病同治理念治疗糖尿病，且有较好的疗效，明确其潜在作用机制具有重要意义。

方法：

该研究基于整合药理学策略及平台(integrative pharmacology platform of traditional Chinese medicine TCMIP)研究交泰丸的作用靶点及机制等，构建其治疗糖尿病的核心靶点网络，进一步对获取靶点进行基因功能及通路富集分析，构建可视化的“交泰丸-活性成分-核心靶点-关键通路”的多层次关联网络。

结果：

共得到交泰丸中活性成分28个。这些成分治疗糖尿病涉及核心靶点187个，包括疾病靶点15个，如精氨酸加压素受体2(vasopressin V2 receptor

AVPR2)，受体活性修饰蛋白1(receptor activity-modifying protein 1

RAMP1)，受体活性修饰蛋白1(receptor activity-modifying protein 3

RAMP3)，胰岛素受体(insulin receptor

INSR)及胰岛素样生长因子受体1(insulin-like growth factor 1 receptor

IGF1R)等；潜在药物靶点71个，如细胞周期蛋白依赖性激酶9 (cyclin-dependent kinase 9

CDK9)，葡萄糖激酶(glucokinase

GCK)，核转录因子-

B抑制剂

(NF-kappa-B inhibitor alpha

NF-

)，核转录因子-

B p100亚型(NF-kappa-B p100 subunit

NFKB2)及缺氧诱导因子1

(hypoxia inducible factor-1 alpha

HIF1

)等。

结论：

交泰丸治疗糖尿病的机制涉及活化腺苷酸环化酶活性、细胞胰高血糖素反应、激活丝裂原活化蛋白激酶(mitogen-activated protein kinase

MAPK)活性、内分泌系统、促性腺激素释放激素(gonadotropin-releasing hormone

GnRH)信号通路、趋化因子及磷脂酰肌醇三激酶-丝氨酸/苏氨酸激酶(phosphatidylinositol 3-kinase-serine/threonine kinases

PI3K-Akt)等生物过程和信号通路等。该研究为深入探讨交泰丸治疗糖尿病的潜在机制提供了科学依据。

Abstract

Objective:

Jiaotaiwan is a classic prescription in traditional Chinese medicine for insomnia. Modern clinical research has proved its anti-diabetes effect by "the same treatment for different diseases" theory

so it is necessary to study its pharmacological mechanism for anti-diabetes effect.

Method:

In this study

the integrative pharmacology platform of traditional Chinese medicine (TCMIP) was used to explore the potential target and mechanism of Jiaotaiwan

and construct its core target network for diabetes. Then the enrich analysis of GO and KEGG on key targets was conducted to build the visual multilayer association network of "Jiaotaiwan-active composition-core target-key pathway" .

Result:

28 active ingredients were obtained from Jiaotaiwan in this study. Its anti-diabetes effect was relevant to 187 core targets

including 15 known disease targets such as vasopressin V2 receptor (AVPR2)

receptor activity-modifying protein 1 (RAMP1)

receptor activity-modifying protein 3 (RAMP3)

insulin receptor (INSR)

and insulin-like growth factor 1 receptor (IGF1R); as well as 71 predictive drug targets such as cyclin-dependent kinase 9 (CDK9)

glucokinase (GCK)

NF-kappa-B inhibitor alpha (NFKBIA)

NF-kappa-B p100 subunit (NFKB2)

and hypoxia inducible factor-1 alpha (HIF1A).

Conclusion:

The anti-diabetes mechanism of Jiaotaiwan may be associated with activation of adenylate cyclase activity

cellular response to glucagon stimulus

activation of mitogen-activated protein kinase (MAPK) activity

endocrine system

gonadotropin-releasing hormone (GnRH) signaling pathway

Chemokine signaling pathway

phosphatidylinositol 3-kinase-serine/threonine kinases (PI3K-Akt) signaling pathway and other related biological processes and pathways. This study provides a scientific evidence for further study of the anti-diabetes mechanism of Jiaotaiwan.

关键词

Keywords

references

许海玉，杨洪军．整合药理学：中药现代研究新模式 [J]. 中国中药杂志， 2014 , 39 ( 3 ): 357 - 362 .

张昌林，吴荣焕，盛泓沁，等．基于网络药理学的葛根芩连汤治疗2型糖尿病的效应机制 [J]. 中国实验方剂学杂志， 2018 , 24 ( 19 ): 179 - 188 .

许海玉，刘振明，付岩，等．中药整合药理学计算平台的开发与应用 [J]. 中国中药杂志， 2017 , 42 ( 18 ): 3633 - 3638 .

张建永，张滨，段灿灿．交泰丸治疗糖尿病的理论基础及应用 [J]. 世界中医药， 2016 , 11 ( 3 ): 554 - 557 .

白永生，袁琳，陆雄．交泰丸治疗糖尿病琐议 [J]. 河南中医， 2009 , 29 ( 3 ): 296 - 297 .

DONG H , WANG J H , ER L F , et al . Jiaotai Pill enhances insulin signaling through phos Phatidylinositol 3·Kinase pathway in skeletal muscle of diabetic rats [J]. Chin J Integer Med , 2013 , 19 ( 9 ): 668 - 674 .

HU N , YUAN L , LU X , et al . Anti-diabetic activities of Jiaotaiwan in db/db mice by augmentation of AMPK protein activity and upregulation of GLUT4 expression [J]. Evid Based Complement Alternat Med , 2013 , doi: 10.1155/2013/180721 doi:10.1155/2013/180721 .

汪健红，陆付耳，董慧，等．不同配伍比例交泰丸对2型糖尿病大鼠的治疗作用 [J]. 中国中药杂志， 2011 , 36 ( 16 ): 2271 - 2276 .

YIN J , YE J , JIA W. Effects and mechanisms of berberine in diabetes treatment [J]. Acta Pharm Sin B , 2012 , 2 ( 4 ): 327 - 334 .

Adisakwattana S . Cinnamic acid and its derivatives: mechanisms for prevention and management of diabetes and its complications [J]. Nutrients , 2017 , 9 ( 2 ): 163 .

BAI Y , CHEN Y , KONG X. Contiguous 22.1-kb deletion embracing AVPR2 and ARHGAP4 genes at novel breakpoints leads to nephrogenic diabetes insipidus in a Chinese pedigree [J]. BMC Nephrol , 2018 , 19 ( 1 ): 26 .

ZHANG Z , LIU X , Morgan D A , et al . Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice [J]. Diabetes , 2011 , 60 ( 4 ): 1063 - 1071 .

Saltiel A R , Kahn C R. Insulin signaling and the regulation of glucose and lipid metabolism [J]. Nature , 2001 , 414 ( 6865 ): 799 - 806 .

Muller Y L , Skelton G , Piaggi P , et al . Identification and functional analysis of a novel G310D variant in the insulin-like growth factor 1 receptor (IGF1R) gene that associates with type 2 diabetes in American Indians [J]. Diabetes Metab Res Rev , 2018 , 34 ( 4 ): e2994 .

ZHOU J , ZHOU S , TANG J , et al . Effect of berberine on Cdk9 and cyclin T1 expressions in myocardium of diabetic rats [J]. J Med Coll PLA , 2008 , 23 ( 1 ): 45 - 51 .

Osbak K K , Colclough K , Saintmartin C , et al . Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia [J]. Hum Mutat , 2009 , 30 ( 11 ): 1512 - 1526 .

Kaldunski M , JIA S , Geoffrey R , et al . Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the Biobreeding rat [J]. Diabetes , 2010 , 59 ( 10 ): 2375 - 2385 .

Fa V D L , Lucassen P L , Akkermans R P , et al . Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a cochrane systematic review and meta-analysis [J]. Diabetes Care , 2005 , 28 ( 1 ): 154 - 163 .

Choi J , Kim K J , Koh E J , et al . Gelidium elegans extract ameliorates type 2 diabetes via regulation of MAPK and PI3K/Akt signaling [J]. Nutrients , 2018 , 10 ( 1 ): e51 .

Würzburger M I , Prelevic G M , SÖnksen P H , et al . Effects of improved blood glucose on insulin-induced hypoglycaemia, TRH, GnRH and exercise texts in insulin-dependent diabetes [J]. Clin Endocrinol , 2010 , 32 ( 6 ): 799 - 807 .

ZHANG Q , XIAO X , LI M , et al . Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine [J]. BMC Complement Altern Med , 2014 , 14 ( 1 ): 188 .

Shanmugam N , Reddy M A , Guha M , et al . High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells [J]. Diabetes , 2003 , 52 ( 5 ): 1256 - 1264 .

Varma S , Lal B K , ZHENG R , et al . Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction [J]. Am J Physiol Heart Circ Physiol , 2005 , 289 ( 4 ): 1744 - 1751 .

Ramara M , Raman T , Priyadarsini A , et al . Protective effect of ferulic acid and resveratrol against alloxan-induced diabetes in mice [J]. Eur J Pharmacol , 2012 , 690 ( 1/3 ): 226 - 235 .

MA X , CHEN Z , WANG L , et al . The pathogenesis of diabetes mellitus by oxidative stress and inflammation: its inhibition by berberine [J]. Front Pharmacol , 2018 , 9 : 782 .

Gonzalezabuin N , Pinent M , Casanovamarti A , et al . Procyanidins and their healthy protective effects against type 2 diabetes [J]. Curr Med Chem , 2015 , 22 ( 1 ): 39 - 50 .

YIN W , LI B , LI X , et al . Anti-inflammatory effects of grape seed procyanidin B2 on a diabetic pancreas [J]. Food Funct , 2015 , 6 ( 9 ): 3065 - 3071 .

朱化珍，陈德兴．分子生物技术在中药复方药理研究中的应用 [J]. 中国实验方剂学杂志， 2011 , 17 ( 7 ): 278 - 280 .

殷小杰，马晓静，王岚，等．三黄泻心汤活血化瘀优势方抗动脉粥样硬化的作用机制 [J]. 中国实验方剂学杂志， 2018 , 24 ( 22 ): 83 - 88 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Borneol on Pharmacodynamics，Pharmacokinetics and Brain Tissue Distribution of Main Active Ingredients of Jiaotaiwan in Depression Model Rats

Research Progress on Signaling Pathways Related to Treatment of Diabetic Cognitive Dysfunction with Traditional Chinese Medicine： A Review

Traditional Chinese Medicine Treatment for Diabetes and Its Complications： A Review

Pathological Mechanism of Diabetes Based on NF-κB Signaling Pathway and Traditional Chinese Medicine Intervention： A Review

Pathogenesis of Diabetes from Theory of Spleen Deficiency Causing Diabetes Based on Intestinal Innate Immunity

Related Author

YU Meishuang

DAI Guoliang

HANG Huaxi

YE Yu

WANG Yiran

SHAO Xuewen

JU Wenzheng

LI Xinrui

Related Institution

Affiliated Hospital of Nanjing University of Chinese Medicine

Shandong Academy of Chinese Medicine

Traditional Chinese Medicine（TCM）;Analysis of Key Disciplines of State Administration of TCM

The First Clinical Medical College，Shandong University of Chinese Medicine

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰